Common treatment for multiple sclerosis may prolong life

Researchers from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients.

The study, published today in the journal Brain, found that people with MS who took a beta interferon drug had a 32 per cent lower mortality risk than those that did not take the drug. This was particularly evident among MS patients who took beta interferon for more than three years.


https://www.sciencedaily.com/releases/2019/03/190318132638.htm

More Posts

scleroseinfo

Vil du hjælpe Sclerose.info ?

Har du lyst til at hjælpe Sclerose.info med vores vigtige arbejde ? Det kræver IKKE at du skal bruger mange timer hver dag –men du

fællesskabets

Fællesskabets positive lys

Fællesskabets positive lys. Være en del af den fælles positive bølge. Sammenholdet, samværet med andre – Glæden i mit indre. De sjove stunder, grin og